Importance of methodology in determining bactericidal and bacteriostatic activities of azlocillin and ticarcillin against Pseudomonas aeruginosa

References

1. Basker M. J., Edmondson R. A. E., Sutherland R. 1979; Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes. Infection 7:67–73
   [Google Scholar]
2. Batchelor F. R., Chain E. B., Hardy T. L., Mansford K. R. L., Rolinson G. N. 1961; 6-aminopenicillanic acid. III. Isolation and purification. Proceedings of the Royal Society B 154:498–508
   [Google Scholar]
3. Brown D., Blowers R. 1978; Disc methods of sensitivity testing and other semiquantitative methods. In Reeves D. S., Phillips I, Williams J. D., Wise R. (eds) Laboratory Methods in Antimicrobial Chemotherapy Churchill Livingstone; Edinburgh: pp 8–30
   [Google Scholar]
4. Cruickshank R., Duguid J. P., Swain R. H. A. 1969; Medical Microbiology. 11th edn E. & S. Livingstone; Edinburgh: p 901
   [Google Scholar]
5. Curtis N. A. C. 1981; Penicillin-binding proteins in theory and practice. Journal of Antimicrobial Chemotherapy 8:85–87
   [Google Scholar]
6. Curtis N. A. C., Orr D., Ross G. W., Boulton M. G. 1979; Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K12 and their antibacterial activity. Antimicrobial Agents and Chemotherapy 15:533–539
   [Google Scholar]
7. EORTC International Antimicrobial Therapy Project Group 1978; Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137:14–29
   [Google Scholar]
8. Fass R. J. 1982; Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test. Antimicrobial Agents and Chemotherapy 22:28–31
   [Google Scholar]
9. Fu K. P., Neu H. C. 1978; Azlocillin and mezlocillin: new ureido penicillins. Antimicrobial Agents and Chemotherapy 13:930–938
   [Google Scholar]
10. Furth A. 1979; The β-lactamases of Pseudomonas aeruginosa. In Hamilton-Miller J. M. T., Smith J. T. (eds) Beta-lactamases Academic Press; London: pp 403–428
    [Google Scholar]
11. Greenwood D., Eley A. 1982; A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal β-lactam antibiotics. Journal of Infectious Diseases 145:110–117
    [Google Scholar]
12. Gwynn M. N., Rolinson G. N. 1980; Selection of variants of Pseudomonas aeruginosa resistant to beta-lactam antibiotics. Infection 8:73–80
    [Google Scholar]
13. Gwynn M. N., Webb L. T., Rolinson G. N. 1981; Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other β-lactam antibiotics. Journal of Infectious Diseases 144:263–269
    [Google Scholar]
14. Kurtz S., Holmes K., Turck M. 1975; Disparity between inhibitory and killing effects of BL-P1654 Antimicrobial Agents and Chemotherapy. 7:215–218
    [Google Scholar]
15. Labia R., Beguin R., Masson J. M., Kazmierczak A. 1982; Cefsulodin and Pseudomonas aeruginosa: the influence of β-lactamases. In Periti P, Grassi G. G. (eds) Current chemotherapy and immunotherapy, 1. American Society of Microbiology Washington: pp 511–513
    [Google Scholar]
16. O’Grady F. (editor) 1978; Ticarcillin (BRL 2288). Proceedings of an international symposium. Excerpta Medica, Amsterdam, International Congress Series. no 445
    [Google Scholar]
17. Phaneuf D., Neu H. C. 1979; Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin and ticarcillin. Antimicrobial Agents and Chemotherapy 16:625–630
    [Google Scholar]
18. Ryan D. M., Monsey D. 1981; Bacterial filamentation and in-vivo efficacy: a comparison of several cephalosporins. Journal of Antimicrobial Chemotherapy 7:57–63
    [Google Scholar]
19. Shah P. P., Briedis D. J., Robson H. G., Conterato J. P. 1979; In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 15:346–350
    [Google Scholar]
20. Siegenthaler W., Weuta H. (eds) 1980; Acylureidopenicillins. Proceedings of an international symposium. Excerpta Medica Amsterdam:
    [Google Scholar]
21. White A. R., Comber K. R., Sutherland R. 1980; Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 18:182–189
    [Google Scholar]
22. Wirth K., Schomerus M., Hengstmann J. H. 1976; Zur Pharmakokinetik von Azlocillin, einem neuen halbsynthetischen Breitspektrumantibiotikum Infection. 4:25–30
    [Google Scholar]